Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedLicence not statedACS medicinal chemistry letters

A High-Throughput Screening Platform for the Discovery of Noncovalent Inhibitors of the ISG15-UBA7 Interaction

5 affiliations
  1. 1Department of Pharmaceutical Sciences, Retzky College of Pharmacy, University of Illinois Chicago, Chicago, IL, 60612, United States
  2. 2Department of Physiology and Biophysics, College of Medicine, University of Illinois Chicago, Chicago, IL, 60612, United States
  3. 3UICentre for Drug Discovery, University of Illinois Chicago, Chicago, IL, 60612, United States
  4. 4High-Throughput Screening Core, Research Resources Center, University of Illinois Chicago, Chicago, IL, 60612, United States
  5. 5University of Illinois Cancer Center, University of Illinois Chicago, Chicago, IL, 60612, United States

Related

  1. 777 High-throughput discovery of rare, functionally potent antigen-reactive TCRs via polyclonal library screening
    Srishti Gupta, Miao Li, Pooja Vaikari +3
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
  2. High-throughput platforms for genetic perturbation screening using CRISPR/Cas9 in human iPSC-derived macrophages for drug discovery
    M. Martufi, E. Karagianni, T. Papanikos +21
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  3. High-Throughput Screening Identifies Proteasome Inhibitors as Potentiators of Type III Interferon JAK-STAT Signaling and Antiviral Immunity
    J.-P. Parisien, C. O Leary, S. Shabani +5
    bioRxivPreprintCC BYFull textImmunologybioRxiv
  4. Discovery of Stereoselective Targeted Covalent Inhibitors of the RAB27-Effector Protein-Protein Interaction.
    Elena De Vita, Adam M Thomas, Delia Brustur +14
    Journal of the American Chemical SocietyPeer-reviewedCC BYFull text1 citedCell biologyEurope PMC
  5. An AI-Enabled Translational Drug Discovery Framework for NALCN Channelopathy: From High-Throughput Screening to Therapeutic Candidate
    Nattaya Thongsepee, Jeremy A Tanner, Srikanth Polusani +8
    HALPreprintCC BY-NC-ND 4.0Full textNeurosciencePharmacology & toxicologyHALbioRxiv
BibTeX
@article{dean2026highthroughput,
  title = {{A High-Throughput Screening Platform for the Discovery of Noncovalent Inhibitors of the ISG15-UBA7 Interaction}},
  author = {Trevor T. Dean and Tatum L. Johnson and Mohamed Haloul and Sweta Misra and Yuri Song and Kiira Ratia and Ekrem Emrah Er and Terry W. Moore},
  journal = {ACS medicinal chemistry letters},
  year = {2026},
  month = oct,
  doi = {10.1021/acsmedchemlett.6c00457},
  url = {https://doi.org/10.1021/acsmedchemlett.6c00457},
}
RIS
TY  - JOUR
TI  - A High-Throughput Screening Platform for the Discovery of Noncovalent Inhibitors of the ISG15-UBA7 Interaction
AU  - Trevor T. Dean
AU  - Tatum L. Johnson
AU  - Mohamed Haloul
AU  - Sweta Misra
AU  - Yuri Song
AU  - Kiira Ratia
AU  - Ekrem Emrah Er
AU  - Terry W. Moore
PY  - 2026
DA  - 2026/10/16
JO  - ACS medicinal chemistry letters
DO  - 10.1021/acsmedchemlett.6c00457
UR  - https://doi.org/10.1021/acsmedchemlett.6c00457
SN  - 1948-5875
ER  -